Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Rab Proteins

Rab Proteins

Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...

Rabies

Rabies

Rabies is a lethal zoonotic disease caused by a single-stranded, negative-sense RNA virus of the Lyssavirus genus, within the family Rhabdoviridae. Its primary mode of transmission to humans is through bites or saliva-contaminated scratches from infected mammals such as dogs, bats, raccoons, or foxes. Transmission can also occur if infectious saliva contacts abraded skin or intact mucous membranes, including the conjunctiva.Viral Entry and Early ReplicationOnce introduced at the bite or scratch...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A computational method to design broad-spectrum T cell-inducing vaccines applied to Betacoronaviruses.

Cell reports methods·2026

Same author

The Establishment of an Indigenous-Led Drinking Water Monitoring Program Leveraging qPCR and Metagenomics Testing in New Zealand.

Water environment research : a research publication of the Water Environment Federation·2026

Same author

Critical Path to First-in-Human Batches of ChAdOx Vectors, Including for Emergency Response.

Vaccines·2026

Same author

Progress and prospects for herpesvirus vaccination using gB antigens.

Frontiers in immunology·2026

Same author

Cruise-ship hantavirus cluster exposes a wider preparedness gap.

Nature·2026

Same author

Intranasal boosting enhances genital tract T cell immunity following ChAdOx1/MVA hrHPV therapeutic vaccination.

NPJ vaccines·2026

Search research articles

Related Experiment Video

Updated: Jun 10, 2026

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

Rabies glycoprotein engineering for improved stability and expression.

Solomon English¹, Sofiya Fedosyuk¹, Francisco Orliacq¹

¹Jenner Institute, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, United Kingdom.

|July 27, 2025

Summary

This summary is machine-generated.

Developing new rabies vaccines is crucial for accessibility. Researchers engineered the rabies virus glycoprotein (RVG) to improve vaccine immunogenicity, but found wild-type RVG sufficient for current mRNA and adenovirus platforms in mice.

Keywords:

Adenovirus Rabies virus glycoprotein Structure-guided design Subunit vaccine mRNA

More Related Videos

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

Published on: May 11, 2020

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

Related Experiment Videos

Last Updated: Jun 10, 2026

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

Published on: May 11, 2020

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

Area of Science:

Vaccinology
Molecular Biology
Immunology

Background:

Current rabies vaccines are costly and require multiple doses, limiting global access.
Developing novel, low-cost vaccines that elicit a robust immune response against rabies virus glycoprotein (RVG) is a priority.

Purpose of the Study:

To investigate structure-guided antigen engineering and transgene cassette optimization for improved rabies vaccine immunogenicity.
To evaluate novel vaccine constructs for enhanced expression, stability, and protective antibody response against rabies virus.

Main Methods:

Evaluated twelve candidate transgene cassette designs, including codon optimization and co-expression strategies.
Screened 72 mutant constructs of RVG for in vitro expression and pre-fusion stability at low pH.
Tested immunogenicity of wild-type RVG and mutant constructs using an mRNA vaccine platform in mice.

Main Results:

Codon optimization improved in vitro expression but not immunogenicity.
Mutant constructs showed enhanced expression and/or stability, with specific double mutants (L271Q + H419L) demonstrating the greatest expression increase.
Neither engineered RVG mutants nor cassette optimizations improved immunogenicity compared to wild-type RVG in mRNA vaccines.

Conclusions:

While certain mutations enhance RVG expression and stability, they did not translate to improved immunogenicity in mRNA vaccines.
Full-length wild-type RVG appears sufficiently stable and expressed for optimal immunogenicity in adenovirus and mRNA rabies vaccines.
Engineered RVG mutants may hold potential for future protein subunit vaccine development.